A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients

Published:2013-05-23 Issue:5 Volume:8 Page:e63322
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Thedrez Aurélie,Lavoué Vincent,Dessarthe Benoit,Daniel Pascale,Henno Sébastien,Jaffre Isabelle,Levêque Jean,Catros Véronique,Cabillic Florian

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites;M Bonneville;Microbes Infect,2005

2. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?;A Thedrez;Immunol Rev,2007

3. Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk;E Scotet;Front Biosci,2008

4. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors;M Bonneville;Curr Opin Immunol,2006

5. Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma;Y Abe;Exp Hematol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RGS2 and female common diseases: a guard of women’s health;Journal of Translational Medicine;2023-08-30

2. Cancer Immunoediting: Immunosurveillance, Immune Equilibrium, and Immune Escape;Cancer Immunology;2020

3. Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors;International Journal of Gynecologic Cancer;2019-11

4. Les CAR-T cells, des cellules tueuses spécifiques d’antigènes tumoraux;médecine/sciences;2019-04

5. A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells;OncoImmunology;2017-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3